The Use of Patient-Reported Outcome Measures in Oncology: Perspectives of Oncologists


ÇALIŞKAN YILDIRIM E., UZUN M., ÖZTOP İ., YAVUZŞEN T.

Journal of Oncological Science, cilt.10, sa.3, ss.125-131, 2024 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 3
  • Basım Tarihi: 2024
  • Doi Numarası: 10.37047/jos.2024-102193
  • Dergi Adı: Journal of Oncological Science
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.125-131
  • Anahtar Kelimeler: oncology, Patient-reported outcomes, patients reported outcome measures, survey
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective: This survey study was designed with the aim of assessing the use and opinions about patient-reported outcome measures (PROM) by healthcare workers in oncology clinics in Türkiye. Material and Methods: A 10-question survey was distributed to medical and radiation oncologists through digital platforms, receiving 334 complete responses. Results: Of the participants, 87.4% worked in medical oncology and 12.6% in radiation oncology clinics, respectively. 56% of participants reported less than 5 years of experience. Among participants, 11.7% of medical oncologists and 25% of radiation oncologists reported using PROMs in daily practice (p<0.05). In oncology clinics, it was revealed that PROMs were mainly used in international clinical studies (27.8%), while it was used in national academic studies with less frequency (21.8%). The use of PROMs appeared to increase with professional experience (p<0.05). Among participants, 53.5% stated they had not used PROMs for any purpose. The two most important obstacles to the use of PROMs were lack of time (62.5%) and lack of assisting personnel (35.2%). 25% of participants stated they did not know anything about PROMs. Conclusion: The rate of PROMs use in oncology clinics in Türkiye is 13%, which is much behind the rest of the world, reflecting possible similar patterns in other low-and middle-income regions. This pioneering study underscores the need for strategic initiatives to embed PROs in cancer care, advocating for reforms in health systems.